nabiximols

{
  "id": "MLC-T-ONC-015401",
  "term": "nabiximols",
  "field": "Oncology and biomedicine",
  "definition": "An herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity. Nabiximols contains a standardized extract of tetrahydrocannabinol (THC), the non-psychoactive cannabinoid cannabidiol (CBD), other minor cannabinoids, flavonoids, and terpenes from two cannabis plant varieties. Cannabinoids interact with G protein-coupled cannabinoid 1 (CB1) receptors in the central nervous system, resulting in analgesic, euphoric, and anticonvulsive effects.",
  "synonyms": [
    "cannabis-based oromucosal spray GW-1000-02",
    "cannabidiol mixture with tetrahydrocannabinol",
    "THC and CBD mixture"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/nabiximols/"
}